On the other hand, osteopontin (OPN), another downstream target of LSF-1, can inhibit the lytic activity of the alternative complement pathway by binding to CFH on the cell surface and therefore prevent tumour cells from immune surveillance, indicating the complex interaction between LSF-1 and CFH (44, 45). Here, SPP1 is linked to neoplasm.